MARC details
| 000 -LEADER |
|---|
| fixed length control field |
03219cim a2200469Ii 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
on1296624485 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OCoLC |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20220418143256.0 |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
|---|
| fixed length control field |
sd fungnnmmneu |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
220214t20222022nyunnnn z n eng d |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
TEFMT |
| Language of cataloging |
eng |
| Description conventions |
rda |
| Transcribing agency |
TEFMT |
| Modifying agency |
TEF |
| -- |
ON8 |
| -- |
OCLCO |
| -- |
OCLCF |
| -- |
NFG |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780063210844 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
0063210843 |
| 024 3# - OTHER STANDARD IDENTIFIER |
|---|
| Standard number or code |
9780063210844 |
| 035 ## - SYSTEM CONTROL NUMBER |
|---|
| System control number |
(OCoLC)1296624485 |
| 092 ## - LOCALLY ASSIGNED DEWEY CALL NUMBER (OCLC) |
|---|
| Classification number |
615.372 |
| Item number |
B774 |
| 049 ## - LOCAL HOLDINGS (OCLC) |
|---|
| Holding library |
NFGA |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Bourla, Albert, |
| Relator term |
author. |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Moonshot : |
| Remainder of title |
inside Pfizer's nine-month race to make the impossible possible / |
| Statement of responsibility, etc |
Dr. Albert Bourla. |
| 246 3# - VARYING FORM OF TITLE |
|---|
| Title proper/short title |
Moon shot |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
Unabridged. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE STATEMENTS |
|---|
| Place of production, publication, distribution, manufacture |
New York, NY : |
| Name of producer, publisher, distributor, manufacturer |
Harper Audio, |
| Date of production, publication, distribution, manufacture |
[2022] |
| 264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE STATEMENTS |
|---|
| Date of production, publication, distribution, manufacture |
©2022 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
6 audio discs (6 1/2 hr.) : |
| Other physical details |
CD audio, digital ; |
| Dimensions |
4 3/4 in. |
| 306 ## - PLAYING TIME |
|---|
| Playing time |
063000 |
| 336 ## - CONTENT TYPE |
|---|
| Content Type Term |
spoken word |
| Content Type Code |
spw |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
|---|
| Media Type Term |
audio |
| Media Type Code |
s |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
|---|
| Carrier Type Term |
audio disc |
| Carrier Type Code |
sd |
| Source |
rdacarrier |
| 344 ## - SOUND CHARACTERISTICS |
|---|
| Type of recording |
digital |
| Source |
rdatr |
| 347 ## - DIGITAL FILE CHARACTERISTICS |
|---|
| File type |
audio file |
| Source |
rdaft |
| 347 ## - DIGITAL FILE CHARACTERISTICS |
|---|
| Encoding format |
CD audio |
| 500 ## - GENERAL NOTE |
|---|
| General note |
Subtitle from container. |
| 511 0# - PARTICIPANT OR PERFORMER NOTE |
|---|
| Participant or performer note |
Read by Stephen Graybill. |
| 500 ## - GENERAL NOTE |
|---|
| General note |
Compact discs. |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc |
A riveting, fast-paced, inside look at one of the most incredible private sector achievements in history, Moonshot recounts the intensive nine months in 2020 when the scientists at Pfizer, under the visionary leadership of Dr. Albert Bourla, made ₁the impossible possible₂ creating, testing, and manufacturing a safe and effective Covid-19 vaccine that previously would have taken years to develop. Dr. Bourla chronicles how the brilliant, dedicated minds at Pfizer, under the enormous strains of the global pandemic, overcame a series of crises that were compounded by social and political unrest and reveals the doubts, decisions, obstacles, and failures they encountered. As Dr. Bourla makes clear, Pfizer's success wasn₂t due to luck; it was because of preparation driven by four simple values Courage, Excellence, Equity, and Joy. It is a story of leadership under the most unprecedented circumstances how Dr. Bourla, a Greek immigrant, a child of Holocaust survivors, and a veterinarian, became the head of one of the world₂s largest corporations and initiated a dramatic transformation of the organization just before a global health crisis would serve to test the organization, its scientists, and its leader, like never before. Moonshot describes best practices that can be used to address the multiple, unprecedented challenges our world faces, reveals Pfizer₂s implementation of scientific breakthroughs at a record-breaking pace, and offers leadership lessons that can help anyone successfully manage their own seemingly unsolvable problems. As Dr. Bourla explains, ₁I am sharing the story of our moonshot the challenges we faced, the lessons we learned, and the core values that allowed us to make it happen in hopes that it might inspire and inform your moonshot, whatever that may be.₂ |
| 610 20 - SUBJECT ADDED ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
Pfizer Inc. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
COVID-19 (Disease) |
| General subdivision |
Prevention. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Viral vaccines. |
| 655 #7 - INDEX TERM--GENRE/FORM |
|---|
| Genre/form data or focus term |
Audiobooks. |
| Source of term |
lcgft |
| 9 (RLIN) |
1862 |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Graybill, Stephen, |
| Relator term |
narrator. |
| 9 (RLIN) |
396058 |
| 994 ## - |
|---|
| -- |
C0 |
| -- |
NFG |
